# Frazier Healthcare Partners: portfolio, investments and team > Frazier Healthcare Partners is a private equity based in United States. 102 investments on record, latest Sept 2019. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/frazier-healthcare-partners (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Frazier Healthcare Partners Filed with the SEC to raise a fund in Mar 2026, closing $200M. Last cheque observed Sep 2019. Email Quiet New fund $200M, Mar 2026 Private equity Seed Series A Series B Health-tech Medicine Therapeutic Follow Frazier Healthcare Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Ffrazier-healthcare-partners) Cheques on record **0%** of best year **0** **cheques in 12 months**, 102 on record Since the last cheque **2614** days **00** hrs **00** min **00** sec Median round **$44M** Rounds led **1 of 102** Sole investor **3 rounds** Exits **21 from the portfolio** Mostly in **United States, 100%** Pitch Frazier Healthcare Partners ## Frazier Healthcare Partners highlights - 01 102 rounds on record - 02 Mostly Series B and Series A: 56% of its rounds - 03 Sole investor in 3 rounds, median $20M - 04 21 exits from the portfolio ## What they do > The Frazier Growth Buyout team is the preferred partner to profitable healthcare companies. From their own website - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Health-tech Medicine Therapeutic - **Based in:** Seattle, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **102 appearances** - **2019** 6 rounds - **Sept** **[Passage Bio](https://millionrounds.com/company/passage-bio)** Series B · US · Endpts **$110M** With 6 others - **May** **[Phathom Pharmaceuticals](https://millionrounds.com/company/phathom-pharmaceuticals)** US · FinSMEs **$140M** *Led* - **Apr** **[Scout Bio](https://millionrounds.com/company/scout-bio)** Series B · US · FinSMEs **$20M** With 5 others - **Mar** **[Imago BioSciences](https://millionrounds.com/company/imago-biosciences)** Series B · US · FinSMEs **$40M** With 6 others - **Feb** **[Recida Therapeutics](https://millionrounds.com/company/recida-therapeutics)** Series A · US · Pehub **$8.5M** Sole investor - **Jan** **[Sojournix](https://millionrounds.com/company/sojournix)** Series C · US · FinSMEs **$44M** With 5 others - **2017** 3 rounds - **Dec** **[Aptinyx](https://millionrounds.com/company/aptinyx)** Series B · US · FinSMEs **$70M** With 15 others - **Apr** **[Cirius Therapeutics](https://millionrounds.com/company/cirius-therapeutics)** Series A · US · FinSMEs **$40M** With 3 others - **Mar** **[SutroVax](https://millionrounds.com/company/sutrovax)** Series B · US · FinSMEs **$60M** With 4 others - **2015** 6 rounds - **Oct** **[Gritstone oncology](https://millionrounds.com/company/gritstone-oncology)** Series A · US **$102M** With 6 others - **Jul** **[AnaptysBio](https://millionrounds.com/company/anaptysbio)** Series D · US **$40M** With 4 others - **Mar** **[Collegium Pharmaceutical](https://millionrounds.com/company/collegium-pharmaceutical)** Venture · US **$50M** With 10 others - **Feb** **[Merganser Biotech](https://millionrounds.com/company/merganser-biotech)** Series A · US **$28M** With 4 others - **Feb** **[Laguna Pharmaceuticals](https://millionrounds.com/company/laguna-pharmaceuticals)** Series B · US **$30M** With 3 others - **Feb** **[Cidara Therapeutics](https://millionrounds.com/company/cidara-therapeutics)** Series B · US **$42M** With 9 others - **2014** 6 rounds - **Dec** **[Allena Pharmaceuticals](https://millionrounds.com/company/allena-pharmaceuticals)** Series B · US **$25M** With 4 others - **Oct** **[Imago BioSciences](https://millionrounds.com/company/imago-biosciences)** Series A · US **$27M** With 3 others - **Sept** **[VentiRx Pharmaceuticals](https://millionrounds.com/company/ventirx-pharmaceuticals)** Series B · US **$51M** With 4 others - **Jun** **[Cidara Therapeutics](https://millionrounds.com/company/cidara-therapeutics)** Series A · US **$32M** With 3 others - **Apr** **[ProNAi Therapeutics](https://millionrounds.com/company/pronai-therapeutics)** Series D · US **$60M** With 8 others - **Jan** **[PowerVision](https://millionrounds.com/company/powervision)** Series D · US **$20M** With 6 others - **2013** 4 rounds - **Sept** **[PreCision Dermatology](https://millionrounds.com/company/precision-dermatology)** Debt · US · pehub.com **$67M** With 7 others - **Jul** **[Alcresta](https://millionrounds.com/company/alcresta)** Series B · US · finsmes.com **$10M** With 2 others - **Mar** **[Achaogen](https://millionrounds.com/company/achaogen)** Series D · US **$19M** With 6 others - **Feb** **[Glaukos](https://millionrounds.com/company/glaukos)** Series F · US · pevc.dowjones.com **$30M** With 6 others - **2012** 4 rounds - **Aug** **[Atterocor](https://millionrounds.com/company/atterocor)** Series A · US · finsmes.com **$16M** With 3 others - **Apr** **[Alcresta](https://millionrounds.com/company/alcresta)** Series A · US · finsmes.com **$10M** With 2 others - **Jan** **[Moximed](https://millionrounds.com/company/moximed)** Growth · US **$1.8M** With 3 others - **Jan** **[Kalidex Pharmaceuticals](https://millionrounds.com/company/kalidex-pharmaceuticals)** Venture · US **$6.5M** With 5 others - **2011** 5 rounds - **Nov** **[Allena Pharmaceuticals](https://millionrounds.com/company/allena-pharmaceuticals)** Series A · US · finsmes.com **$15M** With 2 others - **Nov** **[Rempex Pharmaceuticals](https://millionrounds.com/company/rempex-pharmaceuticals)** Series B · US · rempexpharma.com **$68M** With 4 others - **Jul** **[PowerVision](https://millionrounds.com/company/powervision)** Series C · US · finsmes.com **$24M** With 4 others - **Feb** **[Chimerix](https://millionrounds.com/company/chimerix)** Series F · US · chimerix-inc.com **$45M** With 7 others - **Feb** **[Glaukos](https://millionrounds.com/company/glaukos)** Series E · US · fis.dowjones.com **$30M** With 6 others - **2010** 9 rounds - **Sept** **[Tobira Therapeutics](https://millionrounds.com/company/tobira-therapeutics)** Series B · US · tobiratherapeutics.com **$31M** With 4 others - **Aug** **[Nuon Therapeutics](https://millionrounds.com/company/nuon-therapeutics)** Venture · US · bizjournals.com **$10M** With 2 others - **Jul** **[BARRX Medical](https://millionrounds.com/company/barrx-medical)** Series D · US · barrx.com **$15M** With 5 others - **Jun** **[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Series C · US · calistogapharma.com **$40M** With 5 others - **Jun** **[Incline Therapeutics](https://millionrounds.com/company/incline-therapeutics)** Series A · US · onbiovc.com **$43M** With 5 others - **Jun** **[Zeltiq Aesthetics](https://millionrounds.com/company/zeltiq-aesthetics)** Series D · US · altassets.com **$25M** With 3 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **10 named** AN **Alan N. Frazier** Member of the Issuer's affiliated advisor, Frazier Management, L.L.C. i Filing they signed BJ **Ben Joseph Magnano** Member of the General Partner i Filing they signed BK **Brian Kingston Morfitt** Member of the General Partner i Filing they signed BM **Brian Magnano** Member of the General Partner i Filing they signed JN **James N. Topper** Member of the Issuers' affiliated advisor, Frazier Management, L.L.C. i Filing they signed NJ **Nader Jafari Naini** Member of the General Partner i Filing they signed NR **Nathan Robert Every** Member of the General Partner i Filing they signed PJ **Patrick J. Heron** Member of the Issuer's affiliated advisor, Frazier Management, L.L.C. i Filing they signed RN **Robert N. More** Member of the general partner i Filing they signed SR **Steve Ray Bailey** Chief Financial Officer & Chief Compliance Officer i Form ADV We also hold **94** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$7.7B** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Frazier Management, L.L.C. - **SEC number:** CRD 157324 Funds on its Form ADV **17** private funds, **$4.7B** in gross assets · filed Mar 2024 Private equity **16** Venture **1** - Frazier Healthcare Growth Buyout Fund IX, L.P. *Private equity* 116 investors $1.1B - FH Sunrise Co-Investment I, L.P. *Private equity* 43 investors $715M - FH CSF Holdings, LLC *Private equity* 40 investors $651M - Frazier Healthcare Growth Buyout Fund X, L.P. *Private equity* 100 investors $430M - Frazier Healthcare Growth Buyout Fund X PV, L.P. *Private equity* 46 investors $420M - Frazier Healthcare Growth Buyout Fund IX PV, L.P. *Private equity* 26 investors $338M - Frazier Healthcare Growth Buyout Fund VIII, L.P. *Private equity* 48 investors $337M - Mercury Fortuna Buyer, LLC *Private equity* 17 investors $225M - Frazier Healthcare Growth Buyout Fund VIII PV, L.P. *Private equity* 23 investors $173M - Frazier Healthcare VII, L.P. *Private equity* 39 investors $89M And 7 more on the filing. Who backs their funds ## 2 LPs on record in Frazier Healthcare Partners's funds - **Committed:** $237M - **Funds:** 5 - **Vintages:** 1996 to 2025 The institutions that put money into its funds, which the firm then invests in companies. Source: the pension's own report, latest Mar 2026. - [**California State Teachers Retirement System** 2 funds *$147M*](https://millionrounds.com/fund/california-state-teachers-retirement-system) Fund Vintage Committed Frazier Healthcare Growth XI 2025 $100M Frazier Healthcare Ventures V 2005 $47M - [**Washington State Investment Board** 3 funds *$90M*](https://millionrounds.com/fund/washington-state-investment-board) Fund Vintage Committed Frazier Healthcare IV 2001 $40M Frazier Healthcare III 1998 $40M Frazier Healthcare II 1996 $10M ## What they claim to have backed From their own portfolio page (on their website) **2** of 46 we have independently watched raise [Pharma Packager PCI](https://millionrounds.com/company/toku)[Usrenalcare](https://millionrounds.com/company/u-s-renal-care) Adare Pharma Solutions Adarepharmasolutions Agilitihealth Alteonhealth Bravohealth Brightspringhealth Business Caravel Autism Health Caravel Autism Health Caravel ‘hasn’t skipped Caravelautism Comprehensive Pharmacy Services, Correctcaresolutions Cpspharm Csafeglobal Effectiveschoolsolutions Elevatepfs Eptam Frazier-backed TCGRx acquires Gsms Hopco Knipper Kohlberg and Mubadala Konovo Labsco Leiters Leiters Acquires Facility Luxinfusion Matrix Medical Network Matrixcare Matrixmedicalnetwork Myairlife Parata Patheon Pci Pentechealth Revspringinc Solismammo Tridentcare Triimaging Uniteddermpartners Uniteddigestive Urldefense Vaticahealth Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded. ## Exits from the portfolio Companies it backed that were later bought or listed **21 in all** **[PatientKeeper](https://millionrounds.com/company/patientkeeper)** Bought by [HCA](https://millionrounds.com/fund/hca-healthcare) **Undisclosed** Sept 2014 **[PreCision Dermatology](https://millionrounds.com/company/precision-dermatology)** Bought by Valeant Pharmaceuticals International **$500M** Feb 2014 **[Stromedix](https://millionrounds.com/company/stromedix)** Bought by [Biogen Idec](https://millionrounds.com/fund/biogen-idec) **$750M** Feb 2014 **[Rempex Pharmaceuticals](https://millionrounds.com/company/rempex-pharmaceuticals)** Bought by The Medicines Company **$464M** Dec 2013 **[Barosense](https://millionrounds.com/company/barosense)** Bought by [Boston Scientific](https://millionrounds.com/fund/boston-scientific) **Undisclosed** Jul 2013 **[Zonare Medical Systems](https://millionrounds.com/company/zonare-medical-systems)** Bought by Mindray Medical International **$105M** Jun 2013 **[Portola Pharmaceuticals](https://millionrounds.com/company/portola-pharmaceuticals)** Listed **$100M** May 2013 **[Incline Therapeutics](https://millionrounds.com/company/incline-therapeutics)** Bought by The Medicines Company **Undisclosed** Dec 2012 **[Calibra Medical](https://millionrounds.com/company/calibra-medical)** Bought by [Johnson & Johnson](https://millionrounds.com/fund/johnson-and-johnson) **Undisclosed** Jul 2012 **[BARRX Medical](https://millionrounds.com/company/barrx-medical)** Bought by [Covidien](https://millionrounds.com/fund/covidien) **$325M** Nov 2011 **[Clovis Oncology](https://millionrounds.com/company/clovis-oncology)** Listed **$130M** Nov 2011 **[Calypso Medical](https://millionrounds.com/company/calypso-medical)** Bought by Varian Medical Systems **Undisclosed** Sept 2011 **[Ascension Orthopedics](https://millionrounds.com/company/ascension-orthopedics)** Bought by Integra LifeSciences Holdings **$65M** Sept 2011 **[Calistoga Pharmaceuticals](https://millionrounds.com/company/calistoga-pharmaceuticals)** Bought by [Gilead Sciences](https://millionrounds.com/fund/gilead-sciences) **$375M** Feb 2011 **[Marcadia Biotech](https://millionrounds.com/company/marcadia-biotech)** Bought by Roche **Undisclosed** Dec 2010 **[Xoft](https://millionrounds.com/company/xoft)** Bought by iCAD **$73M** Dec 2010 **[Alnara Pharmaceuticals](https://millionrounds.com/company/alnara-pharmaceuticals)** Bought by [Eli Lilly](https://millionrounds.com/fund/eli-lilly) **Undisclosed** Jul 2010 **[FlowCardia](https://millionrounds.com/company/flowcardia)** Bought by C. R. Bard **Undisclosed** May 2010 **[Intradigm Corporation](https://millionrounds.com/company/intradigm-corporation)** Bought by [Silence Therapeutics](https://millionrounds.com/fund/silence-therapeutics) **Undisclosed** Dec 2009 **[Primaeva Medical](https://millionrounds.com/company/primaeva-medical)** Bought by Syneron Medical **$30M** Oct 2009 The latest 20 here. An exit counts when it came after the firm's first round in the company. From historical deal records. New fund on file **$200M** raised in Mar 2026 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$44M** the round, not its cheque Alone, median **$20M** Led 1 of 102 rounds **1%** - **Sole investor:** 3 rounds - **Last cheque:** Sept 2019 - **Exits:** 21 from the portfolio Rounds by stage said on their site - Series B said *28* - Series A said *25* - Series D *15* - Series C *12* - Venture *11* - Series E *4* - Seed said *-* Cheques by year Led Joined 2000 2019 Often in the room with - [Domain Associates](https://millionrounds.com/fund/domain-associates) 17 - [Alta Partners](https://millionrounds.com/fund/alta-partners) 13 - [Versant Ventures](https://millionrounds.com/fund/versant-ventures) 12 - [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) 10 - [MPM Capital](https://millionrounds.com/fund/mpm-bioimpact) 9 - [Advanced Technology Ventures](https://millionrounds.com/fund/advanced-technology-ventures) 8 **Pitching Frazier Healthcare Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as Frazier Healthcare Partners. A count of rooms they were both in, not a relationship either has claimed. [**Domain Associates** VC firm **17** rounds together](https://millionrounds.com/fund/domain-associates)[**Alta Partners** VC firm **13** rounds together](https://millionrounds.com/fund/alta-partners)[**Versant Ventures** VC firm **12** rounds together](https://millionrounds.com/fund/versant-ventures)[**New Enterprise Associates** VC firm **10** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**MPM Capital** Private equity **9** rounds together](https://millionrounds.com/fund/mpm-bioimpact)[**Advanced Technology Ventures** VC firm **8** rounds together](https://millionrounds.com/fund/advanced-technology-ventures)[**Canaan** VC firm **8** rounds together](https://millionrounds.com/fund/canaan-partners)[**InterWest Partners** VC firm **8** rounds together](https://millionrounds.com/fund/interwest-partners)[**5AM Ventures** VC firm **7** rounds together](https://millionrounds.com/fund/5am-ventures)[**Delphi Ventures** VC firm **7** rounds together](https://millionrounds.com/fund/delphi-ventures)[**OrbiMed** Private equity **7** rounds together](https://millionrounds.com/fund/orbimed)[**Sutter Hill Ventures** VC firm **7** rounds together](https://millionrounds.com/fund/sutter-hill-ventures) ## Recently backed The latest companies Frazier Healthcare Partners put money into. [**Phathom Pharmaceuticals** $140M · May 2019](https://millionrounds.com/company/phathom-pharmaceuticals)[**Aptinyx** $70M · Dec 2017](https://millionrounds.com/company/aptinyx) ## Mentioned on podcasts Episodes that name Frazier Healthcare Partners in their description, not their title. - [The Biotech Startups Podcast](https://millionrounds.com/podcasts/biotech-startups) 7 Sept 2026 · 30 min The Biotech Deal That Became a Leadership Crisis | Philip Borden (3/4) With [Philip Borden](https://millionrounds.com/person/philip-borden) Mentions [Frazier Healthcare Partners](https://millionrounds.com/fund/frazier-healthcare-partners) Apple PodcastsShow page - [Growth Investor](https://millionrounds.com/podcasts/growth-investor) 13 Mar 2024 · 22 min Growth Buyouts in Healthcare: Frazier’s Nader Naini With [Nader Naini](https://millionrounds.com/person/nader-naini) Mentions [Frazier Healthcare Partners](https://millionrounds.com/fund/frazier-healthcare-partners) Apple PodcastsShow page ## Quick answers about Frazier Healthcare Partners ### What does Frazier Healthcare Partners invest in? Frazier Healthcare Partners invests most often at Series B and Series A (56% of the rounds on record), in sectors such as Health-tech, Medicine and Therapeutic. ### How active is Frazier Healthcare Partners? 102 investments on record, 0 of them in the last 12 months, and it led 1. The most recent was in Sept 2019. ### What has Frazier Healthcare Partners invested in recently? Its most recent investments on record: Passage Bio (Series B, Sept 2019), Phathom Pharmaceuticals (Undisclosed round, May 2019) and Scout Bio (Series B, Apr 2019). ### How big are Frazier Healthcare Partners's cheques? The median round it joins is $44M. ### Does Frazier Healthcare Partners lead rounds? Sometimes: it led 1 of its 102 investments on record (1%). ### Where does Frazier Healthcare Partners invest? Most of the companies it backs are in the United States (100%). ### Is Frazier Healthcare Partners investing now? No investments in the last 12 months; the latest was in Sept 2019. ### Who does Frazier Healthcare Partners invest alongside? Most often Domain Associates (17 rounds together), Alta Partners (13 rounds together) and Versant Ventures (12 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=frazier-healthcare-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=frazier-healthcare-partners)